Mukul Agrawal added this pharma stock to his portfolio, bought 1.34% stake – mukul agrawal added kiltch drugs india in portfolio check shareholding share price and performance

Veteran investor Mukul Aggarwal has bought 2,35,000 shares in a pharma company. The name of the company is- Kilich Drugs India Limited. It is a smallcap stock.

Mukul Mahavir Aggarwal’s name is present in the latest shareholding pattern. He bought 1.34% stake in the company during the July-September 2025 quarter.

Promoters hold 63.77% stake in Kilitch Drugs India. The market cap of the company is around ₹650 crore. The face value of the share is ₹10.

Shares of Kilitch Drugs India closed at ₹370 on BSE on Friday, October 24. It has fallen 13% in 3 months. The 52-week high is ₹490 and low is ₹265.60.

The company’s standalone revenue in the June 2025 quarter stood at ₹34.12 crore. Meanwhile, the net profit stood at ₹4.79 crore. Standalone revenue in FY25 was ₹181.59 crore and net profit was ₹31.16 crore.

Kilich Drugs India is starting a greenfield project in Pen, Maharashtra with an investment of ₹160 crore. The first phase is almost completed.

Other major stocks included in Mukul Aggarwal’s portfolio include Ajmera Realty, CEAT, Allcargo Logistics, LT Foods, Deepak Fertilizers, Sula Vineyards, Suryoday Small Finance Bank, Delta Corp, Dredging Corporation of India, Indo Count, Jammu & Kashmir Bank etc.

Source link

Leave a Comment